What is Elicio Therapeutics Inc. (ELTX) stock price today?

Elicio Therapeutics Inc. (ELTX) currently trades at $10.62 per share. The stock has a market capitalization of $215.05M and a P/E ratio of —x.

Is ELTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Elicio Therapeutics Inc. has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

ELTX

Elicio Therapeutics Inc.

NASDAQ: ELTX · HEALTHCARE · BIOTECHNOLOGY

$10.62

+2.91% today

Updated 2026-04-30

Market cap

$215.05M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.58

Dividend yield

—

52W range

$5 – $15

Volume

0.1M

Market cap

$215.05M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.58

Dividend yield

—

52W range

$5 – $15

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$17.50

+64.78%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-6.81M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-28.21M	$-35.20M	$-51.90M	$-39.57M	$-7.72M
EPS	—	—	—	—	$-2.58
Free cash flow	$-22.83M	$-32.76M	$-37.16M	$-36.97M	$-6.81M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ELTX	$215.05M	16	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Elicio Therapeutics Inc. trades at $10.62. Our Smart Value Score of 16/100 indicates the stock is weak.

Frequently asked questions

What is Elicio Therapeutics Inc.'s stock price?

Elicio Therapeutics Inc. (ELTX) trades at $10.62.

Is Elicio Therapeutics Inc. overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of Elicio Therapeutics Inc. (ELTX)?

The analyst target price is $17.50, representing +64.8% upside from the current price of $10.62.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-60,013.00%

Beta1.88

50D MA$11.09

200D MA$9.81

Shares out0.02B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ELTX vs LLY →ELTX vs JNJ →ELTX vs ABBV →Stock screener →